September 1, 2015 / 3:31 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Intermap, Heat Biologics, Penn West

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, Wall Street was lower on Tuesday after China's weak factory data heightened fears of a slowdown in the world's second-largest economy. The Dow Jones industrial average was down 1.82 percent at 16,226.58, the S&P 500 was down 1.79 percent at 1,936.83 and the Nasdaq Composite was down 1.38 percent at 4,710.37.

** TREVENA INC, $9.74, +62.33 pct

The drug developer said on Monday its experimental painkiller met main goal of reducing post-operative pain compared with placebo in a mid-stage study.

Wedbush Securities raises price target to $20 from $15, Cowen & Co increase by $1 to $14.

** NETFLIX INC, $108.2799, -5.87 pct

Iphone maker Apple Inc is looking to move into the original programming business to compete with video streaming companies such as Netflix Inc, Variety reported on Monday.

** INTERNAP CORP, $8.97, +12.55 pct

The company is exploring strategic alternatives and has created a strategy committee of independent directors this year.

** MATRIX SERVICE CO, $21.5, +7.50 pct

The company’s fourth-quarter profit handily beats analysts average estimate

Wall Street is bullish on the stock: 5 of 7 brokerages rate the stock “buy” or higher and 2 “hold”

** AXION POWER INTERNATIONAL INC, $1.9699, -22.75 pct

The lead-carbon battery maker said it received a notification from Nasdaq that it fell short of the minimum $2.5 mln stockholders’ equity for continued listing

** DOLLAR TREE INC, $71.22, -6.61 pct

The discount retailer’s quarterly sales rose less than analysts expected as it focused on closing the acquisition of Family Dollar Stores Inc amid intense competition from retailers such as Wal-Mart Stores Inc.

** HEAT BIOLOGICS INC, $4.01, -17.49 pct

Drug developer says it wound up a mid-stage study of its cancer immunotherapy, HS-110

The company will now start early-study of HS-110 in combination with Bristol-Myers Squibb Co’s Opdivo in patients with a type of lung cancer.

** PENN WEST PETROLEUM LTD, $0.6996, -9.14 pct

The Canadian oil and gas producer said on Tuesday it would only spend cash earned from operations, a step that will shrink growth prospects and a tacit admission that it no longer has access to lending markets amidst the more-than 60 percent drop in oil prices in the past year.

** FREEPORT-MCMORAN INC, $9.93, -6.67 pct

Analysts at Citi Research cut rating on stock to “neutral” from “buy” and cut price target to $12 from $20, saying copper miners were not cutting enough production to stabilise falling prices.

** Exxon Mobil Corp, $72.545, -3.58 pct

** Chevron Corp, $78.77, -2.74 pct

** EP Energy, $6.49, -8.46 pct

** Denbury Resources, $3.89, -10.37 pct

** WPX Energy, $7.09, -3.01 pct

Oil retreats after three days of hefty gains; traders said investors took profits after prices soared more than 8 pct on Monday.

BMO cuts price target on number of oil stocks including EP Energy, Denbury, Noble Energy and WPX Energy, citing expectations of continuing pressure on crude prices for balance of the year.

** OCATA THERAPEUTICS INC, $4.3199, +2.13 pct

The company gets Small Business Innovation Research grant from National Eye Institute, part of the National Institutes of Health

The grant will fund further preclinical development of Ocata’s experimental product to treat retinal degenerative diseases.

** FIAT CHRYSLER AUTOMOBILES, $13.66, -3.33 pct

The company is offering $100 prepaid debit cards to owners of recalled vehicles to help ensure cars and trucks with potential safety defects get repaired. (Compiled by Amrutha Penumudi in Bengaluru; Edited by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below